Abstract
Rhinitis and especially allergic rhinitis (AR) remain the most frequent
hypersensitivity condition, affecting up to a quarter of the population
and impacting upon the quality of life of individual patients and the
health economy. Data, especially in respect to underlying
pathophysiological mechanisms mainly derive from adult studies and are
subsequently extrapolated in the pediatric population. Therapeutic
algorithms for children with rhinitis in children are long based on the
same principles as in adults. We explore and describe novel aspects of
rhinitis, ranging from mechanisms to disease classification, phenotypes,
diagnostic and monitoring tools, and the use of treatments, with focus
on the traits of pediatric age groups.